Acupuncture Treatment for Idiopathic Trigeminal Neuralgia: A Longitudinal Case-Control Double Blinded Study

Idiopathic trigeminal neuralgia represents one of the most debilitating facial pain conditions in existence. This disease affects the trigeminal nerve, one of the main nerves responsible for facial sensation, causing episodes of intense pain, similar to electric shocks, that can last from a few seconds to two minutes. The condition is characterized by the presence of trigger points that precipitate painful attacks and by high pain intensity, interspersed with symptom-free periods. The impact on patients' quality of life is significant, since simple activities such as brushing teeth, speaking, or lightly touching the face can trigger excruciating episodes of pain.

Currently, standard treatment for this condition is based primarily on the use of anticonvulsant medications, especially carbamazepine, which is considered the first-line therapeutic choice. However, about half of patients eventually require neurosurgical interventions to control pain, either due to decreasing medication efficacy over time or due to intolerance of adverse effects. This reality has motivated researchers to investigate alternative treatments that could offer effective relief with fewer adverse effects. Acupuncture emerges as a promising option, known for its analgesic effects through the release of substances such as endorphins, enkephalins, and serotonin, which activate the body's natural pain-suppression systems.

This Brazilian study was conducted with the objective of scientifically evaluating the efficacy of acupuncture in the treatment of idiopathic trigeminal neuralgia. The researchers developed a double-blinded longitudinal controlled study, considered the gold standard for medical research, involving 60 patients diagnosed with the condition and 30 healthy individuals as a control group. Patients were randomly divided into three groups: 15 received true acupuncture, 15 received sham (placebo) acupuncture, and 30 continued only with conventional pharmacologic treatment with carbamazepine. The acupuncture protocol consisted of 10 weekly sessions of 20 minutes each, using specific points based on international consensus for the treatment of facial pain.

Assessments were performed before treatment, immediately after the end of the sessions, and six months later, using validated pain scales, functional questionnaires, and sophisticated quantitative sensory tests.

The results demonstrated significant benefits of true acupuncture compared with the other groups. Only patients who received real acupuncture showed sustained reduction of pain intensity, measured by the visual analog scale, which was maintained even six months after the end of treatment. Interestingly, while the true acupuncture group maintained or even reduced their carbamazepine doses, patients who received sham acupuncture needed to significantly increase their medication. In addition, both acupuncture groups (true and sham) showed initial improvement in secondary muscular pain of the face and limitations of jaw movement, but only the real acupuncture group maintained these benefits over the long term.

Sensory tests revealed that real acupuncture improved facial mechanical sensitivity and increased the threshold for deep pain, suggesting beneficial changes in sensory processing.

For patients suffering from trigeminal neuralgia, these results offer hope for an effective and safe complementary treatment. Acupuncture demonstrated the capacity to provide relief not only from the primary pain of the neuralgia, but also from the secondary muscular pain that frequently accompanies the chronic condition. For health care professionals, the study provides robust scientific evidence that acupuncture can be incorporated into the therapeutic arsenal, especially for patients who experience medication side effects or resistance to pharmacological treatment. The improvement observed in emotional and functional aspects is also relevant, since chronic pain conditions frequently lead to depression and limitations in quality of life.

It is important to recognize some limitations of this study that should be considered when interpreting the results. The relatively small number of participants in each group, especially in the acupuncture groups with 15 people each, may limit the generalizability of the findings. In addition, although the researchers attempted to maintain blinding, it is challenging to create a placebo acupuncture truly indistinguishable from the real one, and some patients may have perceived the difference. The study was also conducted at a single medical center in Brazil, which may influence the applicability of the results to different populations and health care systems.

Despite these limitations, the research represents a valuable contribution to the field, providing quality scientific evidence about a therapy that has been used for millennia, but that lacked rigorous scientific validation for this specific condition. The results suggest that acupuncture deserves serious consideration as a complementary therapeutic option in trigeminal neuralgia, especially when performed by adequately trained professionals and as part of an integrated approach to patient care.